(Q44772343)
Statements
1 reference
CA125 velocity at relapse is a highly significant predictor of survival post relapse: results of a 5-year follow-up survey to a randomized placebo-controlled study of maintenance oregovomab immunotherapy in advanced ovarian cancer (English)
1 reference
Jonathan S Berek
1 reference
Peyton T Taylor
1 reference
Christopher F Nicodemus
1 reference
1 February 2008
1 reference
1 reference
31
1 reference
2
1 reference
207-214
1 reference
Identifiers
1 reference
1 reference